잠시만 기다려 주세요. 로딩중입니다.

Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review

Integrative Medicine Research 2020년 9권 3호 p.11 ~ 11
권승원, 이원행, 진철, 장인수, 문상관, 조기호,
소속 상세정보
권승원 ( Kwon Seung-Won ) - Kyung Hee University College of Korean Medicine Department of Cardiology and Neurology
이원행 ( Lee Won-Haeng ) - Leewonhaeng-Whajubmong Korean Medicine Clinic
진철 ( Jin Chul ) - Kyung Hee University Graduate School Department of Korean Medicine Cardiology and Neurology
장인수 ( Jang In-Soo ) - Woosuk University College of Korean Medicine Department of Internal Medicine
문상관 ( Moon Sang-Kwan ) - Kyung Hee University College of Korean Medicine Department of Cardiology and Neurology
조기호 ( Cho Ki-Ho ) - Kyung Hee University College of Korean Medicine Department of Cardiology and Neurology

Abstract


Background: While the world struggles under the coronavirus disease 2019 (COVID-19) pandemic, a variety of antiviral agents and symptomatic treatments are being administered to patients and urgent clinical trials are underway. Under these circumstances, it is important to explore various possibilities for the treatment of COVID-19 including herbal medicines. Among various herbal medicines, Soshihotang (SSHT, Xiao Chai Hu Tang in Chinese) has been prescribed to treat various viral diseases and is used in combination with other herbal medicines depending on the patient’s symptoms.

Methods: For conducting the present review, we searched electronic databases focusing on the antiviral effect of SSHT in experimental and clinical study until April 2020. The search keywords included SSHT, constituents of SSHT, and antiviral effect. We also searched for materials related to topic directly from websites and published books. Based on these search results, we summarized the results of the included materials in the form of a narrative review.

Results: In a number of recent clinical studies, treatment with SSHT improved the infection status of the respiratory and hepatobiliary systems, and experimental studies demonstrated the antiviral effect of SSHT and its components. Furthermore, SSHT are being used in China?where COVID-19 outbreak first took place?and offer a new option to treat COVID-19.

Conclusion: Based on the present evidences, it is believed that SSHT is likely to be a new therapeutic option for COVID-19. Conducting further studies might provide improved understanding regarding the use of SSHT in treating COVID-19.

키워드

COVID-19; Herbal medicine; Soshihotang; Shosaikoto; Xiao Chai Hu Tang

원문 및 링크아웃 정보

등재저널 정보